| Deler fremragende | 3,294,635 shares |
| Insideraktier | 707.707 shares |
| Insider ejerskab | 21,48 % |
| Total Insiders | 19 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Avenue Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Robert L Davidow
10% Owner -
|
80.000 | 1.067 | |
|
Fortress Biotech, Inc.
10% Owner -
|
439.733 | 439.733 | |
| Jaideep Ashok Gogtay | 0 | ||
| Neil Herskowitz Director - [D] | 97 | 97 | |
| Elizabeth Garrett Ingram Director - [D] | 16.000 | 356 | |
|
InvaGen Pharmaceuticals, Inc.
10% Owner -
|
0 | 0 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| David Jin Interim PFO and COO - [O] | 65.000 | 65.000 | |
| Jay D Kranzler Director - [D] | 559 | 559 | |
| Lucy Lu President, CEO, Director - [D] [O] | 748.949 | 16.643 | |
| Alexandra MacLean Chief Executive Officer, Director - [D] [O] | 170.000 | 170.000 | |
| Thomas Gregory Moore | 0 | ||
| Curtis Gale Oltmans Director - [D] | 49.020 | 1.089 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Jeffrey Paley Director - [D] | 79.663 | 1.770 | |
| Lindsay A Md Rosenwald Director - [D] | 354.318 | 4.724 | |
| Scott Reines Interim Chief Medical Officer - [O] | 45.000 | 1.000 | |
| Akhtar Samad Director - [D] | 64.663 | 1.437 | |
| Nishant Saxena | 0 | ||
| Joseph Walter Vazzano Chief Financial Officer - [O] | 165.757 | 3.683 | |
| Michael S Weiss Director - [D] | 24.663 | 548 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ATXI / Avenue Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ATXI / Avenue Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-06 | 2026-01-02 | 4 | Fortress Biotech, Inc. | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 111.209 | 439.733 | ||||||
| 2025-04-02 | 2025-03-31 | 4 | Fortress Biotech, Inc. | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 33.724 | 328.524 | ||||||
| 2025-01-03 | 3 | Fortress Biotech, Inc. | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 294.800 | ||||||||
| 2024-12-03 | 2024-12-02 | 4 | Herskowitz Neil | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 2,0000 | -23 | -0 | 97 | ||||
| 2024-11-07 | 2024-11-05 | 4 | KRANZLER JAY D | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 2,2400 | -61 | -0 | 559 | ||||
| 2024-10-01 | 2024-09-30 | 4 | KRANZLER JAY D | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 2,5000 | 497 | 1 | 620 | ||||
| 2024-10-01 | 2024-09-27 | 4 | KRANZLER JAY D | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 2,4000 | 3 | 0 | 123 | ||||
| 2024-09-25 | 2024-09-23 | 4 | MacLean Alexandra | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 170.000 | 170.000 | ||||||
| 2024-09-25 | 2024-09-23 | 4 | Jin David | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 65.000 | 65.000 | ||||||
| 2024-04-17 | 2024-04-16 | 4 | Fortress Biotech, Inc. | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 413.507 | 3.547.393 | ||||||
| 2024-01-03 | 2024-01-02 | 4 | Fortress Biotech, Inc. | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 2.101.496 | 3.133.886 | ||||||
| 2023-12-13 | 2023-12-11 | 4 | Davidow Robert L By Spouse | ATXI | Common Stock | I | 0,1400 | -20.000 | -3 | 80.000 | ||||
| 2023-12-13 | 2023-12-11 | 4 | Davidow Robert L Shared investment authority | ATXI | Common Stock | I | 0,1400 | -128.000 | -18 | 147.000 | ||||
| 2023-12-13 | 2023-12-11 | 4 | Davidow Robert L Shared investment and voting authority | ATXI | Common Stock | I | 0,1400 | -126.000 | -18 | 215.800 | ||||
| 2023-12-13 | 2023-12-11 | 4 | Davidow Robert L Trustee for Juliet Davidow 2001 Trust and Alexander Davidow 2010 Trust | ATXI | Common Stock | I | 0,1400 | -61.000 | -9 | 74.000 | ||||
| 2023-12-13 | 2023-12-11 | 4 | Davidow Robert L Joint account with spouse | ATXI | Common Stock | I | 0,1500 | -18.000 | -3 | 22.000 | ||||
| 2023-12-13 | 2023-12-11 | 4 | Davidow Robert L | ATXI | Common Stock | D | 0,1400 | -264.000 | -37 | 681.000 | ||||
| 2023-11-28 | 3 | Davidow Robert L By Spouse | ATXI | Common Stock | I | 100.000 | ||||||||
| 2023-11-28 | 3 | Davidow Robert L Trustee for Juliet Davidow 2001 Trust and Alexander Davidow 2010 Trust | ATXI | Common Stock | I | 135.000 | ||||||||
| 2023-11-28 | 3 | Davidow Robert L Joint account with spouse | ATXI | Common Stock | I | 40.000 | ||||||||
| 2023-11-28 | 3 | Davidow Robert L | ATXI | Common Stock | D | 945.000 | ||||||||
| 2023-11-28 | 3 | Davidow Robert L Shared investment and voting authority | ATXI | Common Stock | I | 341.800 | ||||||||
| 2023-11-28 | 3 | Davidow Robert L Shared investment and voting authority (Loan accounts) | ATXI | Common Stock | I | 90.000 | ||||||||
| 2023-11-28 | 3 | Davidow Robert L Shared investment authority | ATXI | Common Stock | I | 275.000 | ||||||||
| 2023-09-12 | 2023-09-08 | 4 | Fortress Biotech, Inc. | ATXI | Common Stock | D | 0,7200 | 418.410 | 301 | 1.032.390 | ||||
| 2023-09-12 | 2023-09-08 | 4 | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 0,7200 | 348.675 | 251 | 354.318 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Fortress Biotech, Inc. | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 52.419 | 613.980 | ||||||
| 2023-01-04 | 2023-01-03 | 4 | Fortress Biotech, Inc. | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 231.316 | 561.561 | ||||||
| 2023-01-04 | 2022-12-31 | 4 | Fortress Biotech, Inc. | ATXI | COMMON STOCK, PAR VALUE $0.0001 | D | 90.909 | 330.245 | ||||||
| 2022-10-13 | 2022-10-11 | 4 | InvaGen Pharmaceuticals, Inc. | ATXI | Common Stock, par value $0.0001 per share | D | 7,7140 | -388.888 | -3.000 | 0 | ||||
| 2021-12-21 | 2021-12-17 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 20.000 | 183.744 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 49.020 | 163.744 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | KRANZLER JAY D | ATXI | Common Stock | D | 20.000 | 133.683 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | KRANZLER JAY D | ATXI | Common Stock | D | 49.020 | 113.683 | ||||||
| 2021-12-21 | 2021-12-17 | 4 | Oltmans Curtis Gale | ATXI | Common Stock | D | 49.020 | 49.020 | ||||||
| 2021-12-20 | 2021-12-17 | 4 | Lu Lucy | ATXI | Common Stock | D | 411.616 | 748.949 | ||||||
| 2021-12-20 | 2021-12-17 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 100.505 | 165.757 | ||||||
| 2021-09-15 | 2021-09-15 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 1,6200 | -7.160 | -12 | 65.252 | ||||
| 2021-05-07 | 2021-05-06 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 3,9900 | 2.500 | 10 | 134.724 | ||||
| 2020-08-21 | 2020-08-20 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 12,1300 | -3.840 | -47 | 57.412 | ||||
| 2020-06-16 | 2020-06-16 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 10.000 | 132.224 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | KRANZLER JAY D | ATXI | Common Stock | D | 10.000 | 84.663 | ||||||
| 2020-03-10 | 2020-03-10 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 7,9400 | 1.889 | 15 | 61.252 | ||||
| 2020-03-10 | 2020-03-09 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 7,9700 | 100 | 1 | 59.363 | ||||
| 2020-03-10 | 2020-03-09 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 7,9900 | 1.400 | 11 | 59.263 | ||||
| 2020-03-02 | 2020-02-27 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 8,2000 | 2.400 | 20 | 122.224 | ||||
| 2020-03-02 | 2020-02-26 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 8,7300 | 161 | 1 | 119.824 | ||||
| 2020-02-25 | 2020-02-25 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 9,3100 | 10.000 | 93 | 119.663 | ||||
| 2020-02-25 | 2020-02-25 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 9,0900 | 1.200 | 11 | 57.863 | ||||
| 2020-02-13 | 2020-02-12 | 4 | Lu Lucy | ATXI | Restricted Stock Units | D | 0,00 | 110.959 | 246.576 | |||||
| 2020-02-13 | 2020-02-12 | 4 | Vazzano Joseph Walter | ATXI | Restricted Stock Units | D | 0,00 | 22.727 | 50.505 | |||||
| 2019-12-31 | 3 | InvaGen Pharmaceuticals, Inc. See Footnotes | ATXI | Class A Preferred Stock, par value $0.0001 per share | I | 10.256.762 | ||||||||
| 2019-12-31 | 3 | InvaGen Pharmaceuticals, Inc. See Footnotes | ATXI | Common Stock, par value $0.0001 per share | I | 13.930.191 | ||||||||
| 2019-12-31 | 3 | InvaGen Pharmaceuticals, Inc. | ATXI | Common Stock, par value $0.0001 per share | D | 15.840.095 | ||||||||
| 2019-12-31 | 3 | InvaGen Pharmaceuticals, Inc. See Footnotes | ATXI | Class A Preferred Stock, par value $0.0001 per share | I | 10.256.762 | ||||||||
| 2019-12-31 | 3 | InvaGen Pharmaceuticals, Inc. See Footnotes | ATXI | Common Stock, par value $0.0001 per share | I | 13.930.191 | ||||||||
| 2019-12-31 | 3 | InvaGen Pharmaceuticals, Inc. See Footnotes | ATXI | Class A Preferred Stock, par value $0.0001 per share | I | 10.256.762 | ||||||||
| 2019-12-31 | 3 | InvaGen Pharmaceuticals, Inc. See Footnotes | ATXI | Common Stock, par value $0.0001 per share | I | 13.930.191 | ||||||||
| 2019-12-31 | 3 | InvaGen Pharmaceuticals, Inc. | ATXI | Common Stock, par value $0.0001 per share | D | 15.840.095 | ||||||||
| 2019-12-31 | 3 | InvaGen Pharmaceuticals, Inc. | ATXI | Common Stock, par value $0.0001 per share | D | 15.840.095 | ||||||||
| 2019-09-16 | 2019-09-12 | 4 | Ingram Elizabeth Garrett | ATXI | Common Stock | D | 6,2700 | 16.000 | 100 | 16.000 | ||||
| 2019-08-28 | 2019-08-27 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 10.000 | 109.663 | ||||||
| 2019-08-28 | 2019-08-27 | 4 | KRANZLER JAY D | ATXI | Common Stock | D | 10.000 | 74.663 | ||||||
| 2019-08-12 | 2019-08-09 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 5,5600 | -2.375 | -13 | 56.663 | ||||
| 2019-08-12 | 2019-08-08 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 5,6200 | -2.313 | -13 | 59.038 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,8300 | 2.000 | 12 | 99.663 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,8800 | 3.000 | 18 | 97.663 | ||||
| 2019-06-05 | 2019-06-03 | 4 | Lu Lucy | ATXI | Restricted Stock Units | D | 0,00 | 135.617 | 135.617 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Vazzano Joseph Walter | ATXI | Restricted Stock Units | D | 0,00 | 27.778 | 27.778 | |||||
| 2019-04-15 | 2019-04-15 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 4,5200 | 1.000 | 5 | 94.663 | ||||
| 2019-03-29 | 2019-03-29 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,1100 | 1.400 | 7 | 93.663 | ||||
| 2019-03-29 | 2019-03-28 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,1100 | 600 | 3 | 92.263 | ||||
| 2019-02-25 | 2019-02-25 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,4600 | 5.000 | 27 | 91.663 | ||||
| 2019-02-06 | 2019-02-05 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,7700 | 1.850 | 11 | 86.663 | ||||
| 2019-02-06 | 2019-02-04 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,9100 | 7.000 | 41 | 84.813 | ||||
| 2019-02-01 | 2019-01-30 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,9100 | 650 | 4 | 77.813 | ||||
| 2019-01-30 | 2019-01-29 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,9100 | 8.553 | 51 | 77.163 | ||||
| 2019-01-30 | 2019-01-28 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,8400 | 1.447 | 8 | 68.610 | ||||
| 2018-12-12 | 2018-12-10 | 4 | Paley Jeffrey | ATXI | Common Stock | D | 4,7600 | 5.000 | 24 | 79.663 | ||||
| 2018-12-12 | 2018-12-03 | 4 | Paley Jeffrey | ATXI | Common Stock | D | 5,4754 | 10.000 | 55 | 74.663 | ||||
| 2018-08-08 | 2018-08-07 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 14.663 | 67.163 | ||||||
| 2018-08-08 | 2018-08-07 | 4 | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 14.663 | 84.663 | ||||||
| 2018-08-08 | 2018-08-07 | 4 | Lu Lucy | ATXI | Common Stock | D | 250.000 | 807.333 | ||||||
| 2018-08-08 | 2018-08-07 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 30.000 | 61.351 | ||||||
| 2018-08-08 | 2018-08-07 | 4 | SAMAD AKHTAR | ATXI | Common Stock | D | 14.663 | 64.663 | ||||||
| 2018-08-08 | 2018-08-07 | 4 | Paley Jeffrey | ATXI | Common Stock | D | 14.663 | 64.663 | ||||||
| 2018-08-08 | 2018-08-07 | 4 | WEISS MICHAEL S | ATXI | Common Stock | D | 14.663 | 24.663 | ||||||
| 2018-08-08 | 2018-08-07 | 4 | Reines Scott | ATXI | Common Stock | D | 10.000 | 45.000 | ||||||
| 2018-08-08 | 2018-08-07 | 4 | KRANZLER JAY D | ATXI | Common Stock | D | 14.663 | 64.663 | ||||||
| 2018-06-28 | 2018-06-28 | 4 | Vazzano Joseph Walter | ATXI | Common Stock | D | 3,6600 | 1.351 | 5 | 31.351 | ||||
| 2018-06-15 | 2018-06-14 | 4 | Lu Lucy | ATXI | Common Stock | D | 4,0000 | 5.000 | 20 | 557.333 | ||||
| 2018-06-12 | 2018-06-08 | 4/A | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 4,3421 | 5.234 | 23 | 70.000 | ||||
| 2018-06-12 | 2018-06-07 | 4/A | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 4,3222 | 14.800 | 64 | 64.766 | ||||
| 2018-06-12 | 2018-06-06 | 4/A | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 4,3490 | 9.100 | 40 | 49.966 | ||||
| 2018-06-12 | 2018-06-05 | 4/A | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 4,2796 | 8.400 | 36 | 40.866 | ||||
| 2018-06-12 | 2018-06-04 | 4/A | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 4,1897 | 3.800 | 16 | 32.466 | ||||
| 2018-06-12 | 2018-06-01 | 4/A | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 4,1545 | 8.666 | 36 | 28.666 | ||||
| 2018-06-11 | 2018-06-08 | 4 | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 4,3400 | 5.234 | 23 | 25.234 | ||||
| 2018-04-25 | 2018-04-25 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 3,8000 | 1.000 | 4 | 52.500 | ||||
| 2017-10-18 | 2017-10-17 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,0100 | 1.000 | 5 | 51.500 | ||||
| 2017-10-10 | 2017-10-09 | 4 | Herskowitz Neil | ATXI | Common Stock | D | 5,2400 | 500 | 3 | 50.500 | ||||
| 2017-10-10 | 2017-10-09 | 4 | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 5,4000 | 1.350 | 7 | 20.000 | ||||
| 2017-10-10 | 2017-10-06 | 4 | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 5,6300 | 2.900 | 16 | 18.650 | ||||
| 2017-10-10 | 2017-10-05 | 4 | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 5,6000 | 3.550 | 20 | 15.750 | ||||
| 2017-10-10 | 2017-10-04 | 4 | ROSENWALD LINDSAY A MD | ATXI | Common Stock | D | 5,6000 | 2.200 | 12 | 12.200 | ||||
| 2017-10-02 | 2017-09-28 | 4 | Lu Lucy | ATXI | Common Stock | D | 5,2000 | 4.000 | 21 | 552.333 | ||||
| 2017-09-11 | 3 | KRANZLER JAY D | ATXI | Common Stock (Restricted) | D | 100.000 | ||||||||
| 2017-09-11 | 3 | KRANZLER JAY D | ATXI | Common Stock (Restricted) | D | 100.000 | ||||||||
| 2017-09-06 | 3 | Reines Scott | ATXI | Common Stock | D | 70.000 | ||||||||
| 2017-09-06 | 3 | Reines Scott | ATXI | Common Stock | D | 70.000 | ||||||||
| 2017-08-23 | 3 | Fortress Biotech, Inc. | ATXI | Class A Preferred Stock | D | 3.816.259 | ||||||||
| 2017-08-23 | 3 | Fortress Biotech, Inc. | ATXI | Common Stock | D | 6.882.518 | ||||||||
| 2017-08-23 | 3 | Fortress Biotech, Inc. | ATXI | Class A Preferred Stock | D | 3.816.259 | ||||||||
| 2017-08-23 | 3 | Fortress Biotech, Inc. | ATXI | Common Stock | D | 6.882.518 | ||||||||
| 2017-08-22 | 3 | Vazzano Joseph Walter | ATXI | Common Stock (Restricted) | D | 60.000 | ||||||||
| 2017-08-22 | 3 | Vazzano Joseph Walter | ATXI | Common Stock (Restricted) | D | 60.000 | ||||||||
| 2017-08-18 | 3 | Herskowitz Neil | ATXI | Common Stock (Restricted) | D | 100.000 | ||||||||
| 2017-08-18 | 3 | Herskowitz Neil | ATXI | Common Stock (Restricted) | D | 100.000 | ||||||||
| 2017-08-18 | 3 | SAMAD AKHTAR | ATXI | Common Stock (Restricted) | D | 100.000 | ||||||||
| 2017-08-18 | 3 | SAMAD AKHTAR | ATXI | Common Stock (Restricted) | D | 100.000 | ||||||||
| 2017-08-18 | 3 | WEISS MICHAEL S | ATXI | Common Stock (Restricted) | D | 20.000 | ||||||||
| 2017-08-18 | 3 | WEISS MICHAEL S | ATXI | Common Stock (Restricted) | D | 20.000 | ||||||||
| 2017-08-18 | 3 | Lu Lucy | ATXI | Common Stock (Restricted) | D | 1.096.666 | ||||||||
| 2017-08-18 | 3 | Lu Lucy | ATXI | Common Stock (Restricted) | D | 1.096.666 | ||||||||
| 2017-08-18 | 3 | Paley Jeffrey | ATXI | Common Stock (Restricted) | D | 100.000 | ||||||||
| 2017-08-18 | 3 | Paley Jeffrey | ATXI | Common Stock (Restricted) | D | 100.000 | ||||||||
| 2017-08-18 | 3 | ROSENWALD LINDSAY A MD | ATXI | Common Stock (Restricted) | D | 20.000 | ||||||||
| 2017-08-18 | 3 | ROSENWALD LINDSAY A MD | ATXI | Common Stock (Restricted) | D | 20.000 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
